Search

everythinglearnresearchcommunity

for

Search:↓

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

The document did not provide enough information to summarize the causes of hair loss in pre- and postmenopausal women.

High-dose finasteride effectively treats hair loss in postmenopausal women.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.

Oral and topical finasteride are effective and safe for treating female hair loss.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.